Form 8-K - Current report:
SEC Accession No. 0001683168-25-000431
Filing Date
2025-01-17
Accepted
2025-01-17 17:22:08
Documents
19
Period of Report
2025-01-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acon_8k.htm   iXBRL 8-K 45531
2 FORM OF SERIES A WARRANT acon_ex0401.htm EX-4.1 177201
3 FORM OF SERIES B WARRANT acon_ex0402.htm EX-4.2 153729
4 FORM OF PRE-FUNDED WARRANT acon_ex0403.htm EX-4.3 116800
5 UNDERWRITING AGREEMENT, DATED JANUARY 15, 2025, BETWEEN THE COMPANY AND DAWSON J acon_ex1001.htm EX-10.1 259437
6 FORM OF LOCK-UP AGREEMENT acon_ex1002.htm EX-10.2 17800
  Complete submission text file 0001683168-25-000431.txt   1151738

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE acon-20250115.xsd EX-101.SCH 3788
8 XBRL DEFINITION FILE acon-20250115_def.xml EX-101.DEF 26648
9 XBRL LABEL FILE acon-20250115_lab.xml EX-101.LAB 36765
10 XBRL PRESENTATION FILE acon-20250115_pre.xml EX-101.PRE 25272
21 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k_htm.xml XML 5794
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 25539629
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)